Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment weighted analysis

Autor: G. Marcq, R. Kool, A. Dragomir, G.S. Kulkarni, R.H. Breau, M. Kim, I. Busca, H. Abdi, M. Dawidek, M. Uy, G. Fervaha, F.L. Cury, N. Alimohamed, J. Izawa, C. Jeldres, R. Rendon, B. Shayegan, R. Siemens, P.C. Black, W. Kassouf

Publikováno v: European Urology. 83:S1888-S1889

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee2f6188e425a34111188fc292e743c7
https://doi.org/10.1016/s0302-2838(23)01335-0

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis.

Autor: Kool R; Department of Urology, McGill University Health Centre, Montreal, QC, Canada; Department of Abdominal Surgery, Division of Urologic Oncology, Erasto Gaertner-Cancer Center, Curitiba, Brazil., Dragomir A; Department of Urology, McGill University Health Centre, Montreal, QC, Canada., Kulkarni GS; Department of Surgery (Urology), Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada., Marcq G; Department of Urology, McGill University Health Centre, Montreal, QC, Canada; Urology Department, Claude Huriez Hospital, CHU Lille, Lille, France; CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, University of Lille, Lille, France., Breau RH; Division of Urology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Kim M; Department of Surgery (Urology), Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada., Busca I; Department of Radiation Oncology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Abdi H; Division of Urology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Dawidek M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Uy M; Division of Urology, McMaster University, Hamilton, ON, Canada., Fervaha G; Department of Urology, Queen's University, Kingston, ON, Canada., Cury FL; Department of Urology, McGill University Health Centre, Montreal, QC, Canada; Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada., Alimohamed N; Division of Medical Oncology, University of Calgary, Calgary, AB, Canada., Izawa J; Division of Urology, Western University, London, ON, Canada., Jeldres C; Division of Urology, University of Sherbrooke, Sherbrooke, QC, Canada., Rendon R; Department of Urology, Dalhousie University, Halifax, NS, Canada., Shayegan B; Division of Urology, McMaster University, Hamilton, ON, Canada., Siemens R; Department of Urology, Queen's University, Kingston, ON, Canada., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Kassouf W; Department of Urology, McGill University Health Centre, Montreal, QC, Canada. Electronic address: wassim.kassouf.med@ssss.gouv.qc.ca.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1350-1357. Date of Electronic Publication: 2024 Feb 06.